Parallel Bio Raises $21M in Series A Funding

| Posted on |

Here’s the information extracted from the provided text about Parallel Bio:

Company Details

  • Startup: Parallel Bio
  • Founder/CEO: Robert DiFazio
  • Location: Cambridge, MA

Fundraising Details

  • Funding Amount: $21M
  • Funding Series: Series A
  • Date of Fundraise: December 6, 2025

Investors

  • Lead Investor: AIX Ventures
  • Participation from:
    • Amplo
    • Marc Benioff (Founder and CEO of Salesforce)
    • Metaplanet
    • Humba Ventures
    • Atypical Ventures
    • Undeterred Capital
    • Jeff Dean

Purpose of Funds

  • Scale AI and automation capabilities of their organoid-based immune system platform
  • Expand team of scientists and engineers
  • Sign new pharmaceutical partnerships

Additional Information

  • Platform: Combines organoids and AI for human-first drug discovery, replicating the human immune system for drug success predictions.
  • Clinical Partner: Centivax for a flu vaccine called Centi-Flu in manufacturing stages for human clinical trials.

Source link

2025-06-12 09:28:19